National Wealth Management Group LLC purchased a new stake in shares of Xylem Inc. (NYSE:XYL – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 3,911 shares of the industrial products company’s stock, valued at approximately $577,000.
A number of other large investors have also modified their holdings of XYL. Hanson & Doremus Investment Management raised its stake in Xylem by 0.9% in the 2nd quarter. Hanson & Doremus Investment Management now owns 8,516 shares of the industrial products company’s stock valued at $1,102,000 after purchasing an additional 77 shares during the last quarter. Princeton Global Asset Management LLC lifted its stake in shares of Xylem by 2.1% in the second quarter. Princeton Global Asset Management LLC now owns 3,801 shares of the industrial products company’s stock worth $492,000 after buying an additional 79 shares in the last quarter. Private Trust Co. NA boosted its position in Xylem by 22.4% during the third quarter. Private Trust Co. NA now owns 459 shares of the industrial products company’s stock worth $68,000 after acquiring an additional 84 shares during the last quarter. Ascent Wealth Partners LLC boosted its position in Xylem by 0.6% during the third quarter. Ascent Wealth Partners LLC now owns 14,385 shares of the industrial products company’s stock worth $2,122,000 after acquiring an additional 87 shares during the last quarter. Finally, Courier Capital LLC grew its stake in Xylem by 4.8% during the 3rd quarter. Courier Capital LLC now owns 1,989 shares of the industrial products company’s stock valued at $293,000 after acquiring an additional 91 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have weighed in on XYL. Robert W. Baird set a $178.00 target price on shares of Xylem in a research note on Wednesday, October 29th. Zacks Research downgraded Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Citigroup upped their target price on Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. Wall Street Zen lowered Xylem from a “buy” rating to a “hold” rating in a report on Saturday, December 27th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Xylem in a research report on Monday, December 29th. Nine research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $165.80.
Insiders Place Their Bets
In other news, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director directly owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. The trade was a 9.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Claudia S. Toussaint sold 10,421 shares of the business’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the transaction, the executive vice president owned 31,250 shares of the company’s stock, valued at approximately $4,770,000. The trade was a 25.01% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.27% of the stock is currently owned by company insiders.
Xylem Price Performance
Shares of XYL opened at $141.06 on Monday. The stock has a market cap of $34.34 billion, a PE ratio of 36.26, a P/E/G ratio of 2.00 and a beta of 1.17. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.50. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $154.27. The firm has a 50-day simple moving average of $139.66 and a two-hundred day simple moving average of $141.61.
Xylem (NYSE:XYL – Get Free Report) last issued its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.14. The business had revenue of $2.27 billion for the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The business’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.11 earnings per share. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th were given a $0.40 dividend. The ex-dividend date of this dividend was Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem’s dividend payout ratio is currently 41.13%.
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Further Reading
- Five stocks we like better than Xylem
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- The biggest scam in the history of gold markets in unwinding
- Buy This Stock at 9:30 AM on MONDAY!
- What Expenses Can Be Deducted From Capital Gains Tax?
- Trump Planning to Use Public Law 63-43: Prepare Now
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
